Column Group Management LP, 10% Owner, Ten Percent Owner Other at NGM BIOPHARMACEUTICALS INC (NGM), bought 14,983,134 shares at $16.00 ($30.2M) on 2019-04-08, disclosed to the SEC on 2019-04-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 13,093,134 | $0 | 0.0% |
| 2 | $16.00 | 15,000 | $240K | 0.8% |
| 3 | $16.00 | 1,875,000 | $30.0M | 99.2% |
| Total | $2.02 avg | 14,983,134 | $30.2M | 100% |
| Filing → |
| NGM | BUY | 2020-04-07 | $3.9M | — | Filing → |
| NGM | BUY | 2019-11-06 | $202K | — | Filing → |
| NGM | BUY | 2019-08-05 | $61K | — | Filing → |